4.4 Review

Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease A Systematic Review and Meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry

Colleen R. Kelly et al.

Summary: This study demonstrated the high effectiveness and good safety profile of FMT for CDI. Assessment of new conditions at long-term follow-up will be important for determining the full safety profile of FMT as this registry grows.

GASTROENTEROLOGY (2021)

Review Infectious Diseases

Predictors of failure after fecal microbiota transplantation for recurrent Clostridioides difficile infection: a systematic review and meta-analysis

Raseen Tariq et al.

Summary: Fecal microbiota transplantation (FMT) is an effective therapy for CDI, but has a failure rate of around 15%. Factors such as use of non-CDI antibiotics, presence of inflammatory bowel disease, poor bowel preparation, CDI-related hospitalization before FMT, inpatient FMT, and severe CDI are associated with increased risk of FMT failure. Modifiable factors like antibiotic use post-FMT and good bowel preparation can lower the risk of failure. Patients with non-modifiable risk factors should be more vigilant for recurrent symptoms after FMT.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Article Gastroenterology & Hepatology

Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection

Srishti Saha et al.

Summary: Fecal microbiota transplantation (FMT) is highly effective for treating recurrent Clostridioides difficile infection (CDI) and appears to be safe. Common symptoms during short-term follow-up include diarrhea and constipation, while long-term follow-up revealed new diagnoses that should be further explored in future studies.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection

Jessica R. Allegretti et al.

Summary: This study explored the use of FMT in patients with IBD-CDI and found that it may lead to improvements in IBD outcomes among patients with Crohn's disease and ulcerative colitis. The study suggests that FMT could be a potential treatment option for these patients with recurrent CDI.

INFLAMMATORY BOWEL DISEASES (2021)

Article Gastroenterology & Hepatology

Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease

Raseen Tariq et al.

INFLAMMATORY BOWEL DISEASES (2020)

Review Biochemistry & Molecular Biology

The Gut Microbiota in the First Decade of Life

Muriel Derrien et al.

TRENDS IN MICROBIOLOGY (2019)

Article Gastroenterology & Hepatology

Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease

Stanley Cho et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)

Article Gastroenterology & Hepatology

Fecal Microbiota Transplantation

Stephen M. Vindigni et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2017)

Article Gastroenterology & Hepatology

Fecal microbiota transplantation for Clostridium difficile infection in patients with ileal pouches

Nan Lan et al.

GASTROENTEROLOGY REPORT (2017)

Article Gastroenterology & Hepatology

Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

Alireza Meighani et al.

DIGESTIVE DISEASES AND SCIENCES (2017)

Letter Gastroenterology & Hepatology

Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile

Amar Mandalia et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2016)

Article Gastroenterology & Hepatology

Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection

Alexander Khoruts et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Medicine, General & Internal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Article Medicine, General & Internal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Meeting Abstract Gastroenterology & Hepatology

Safety and Efficacy of Fecal Microbiota Transplantation for Clostridium Difficile in a Cohort of Patients with a Severe Infection And/or IBD

Rebecca Roediger et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Fecal Microbiota Transplantation Via Nasogastric Tube for Recurrent Clostridium difficile Infection in Pediatric Patients

Matthew P. Kronman et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2015)

Article Gastroenterology & Hepatology

Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients

Colleen R. Kelly et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Fecal Transplant for Recurrent Clostridium difficile Infection in Children With and Without Inflammatory Bowel Disease

George H. Russell et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)

Review Gastroenterology & Hepatology

Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis

Zain Kassam et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

Article Gastroenterology & Hepatology

Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis

S. K. Murthy et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)

Article Gastroenterology & Hepatology

Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis

Udayakumar Navaneethan et al.

JOURNAL OF CROHNS & COLITIS (2012)

Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)

Article Gastroenterology & Hepatology

Impact of Clostridium difficile on inflammatory bowel disease

Mazen Issa et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)